vs

Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and PACS Group, Inc. (PACS). Click either name above to swap in a different company.

PACS Group, Inc. is the larger business by last-quarter revenue ($1.4B vs $1.0B, roughly 1.3× Everus Construction Group, Inc.). Everus Construction Group, Inc. runs the higher net margin — 5.5% vs 4.4%, a 1.1% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 18.4%). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 20.5%).

ECG vs PACS — Head-to-Head

Bigger by revenue
PACS
PACS
1.3× larger
PACS
$1.4B
$1.0B
ECG
Growing faster (revenue YoY)
ECG
ECG
+14.7% gap
ECG
33.2%
18.4%
PACS
Higher net margin
ECG
ECG
1.1% more per $
ECG
5.5%
4.4%
PACS
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
20.5%
PACS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ECG
ECG
PACS
PACS
Revenue
$1.0B
$1.4B
Net Profit
$55.3M
$59.7M
Gross Margin
11.6%
Operating Margin
6.8%
7.0%
Net Margin
5.5%
4.4%
Revenue YoY
33.2%
18.4%
Net Profit YoY
60.4%
3022.5%
EPS (diluted)
$1.09
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECG
ECG
PACS
PACS
Q4 25
$1.0B
$1.4B
Q3 25
$986.8M
$1.3B
Q2 25
$921.5M
$1.3B
Q1 25
$826.6M
$1.3B
Q4 24
$759.6M
$1.1B
Q3 24
$761.0M
$1.0B
Q2 24
$703.4M
$981.4M
Q1 24
$625.7M
$934.3M
Net Profit
ECG
ECG
PACS
PACS
Q4 25
$55.3M
$59.7M
Q3 25
$57.0M
$52.4M
Q2 25
$52.8M
$51.0M
Q1 25
$36.7M
$28.5M
Q4 24
$34.5M
$1.9M
Q3 24
$41.8M
$15.6M
Q2 24
$39.0M
$-10.9M
Q1 24
$28.2M
$49.1M
Gross Margin
ECG
ECG
PACS
PACS
Q4 25
11.6%
Q3 25
12.6%
Q2 25
13.0%
Q1 25
11.2%
Q4 24
11.4%
Q3 24
11.8%
17.1%
Q2 24
12.6%
22.3%
Q1 24
11.9%
21.2%
Operating Margin
ECG
ECG
PACS
PACS
Q4 25
6.8%
7.0%
Q3 25
7.3%
6.4%
Q2 25
7.9%
6.2%
Q1 25
6.2%
3.8%
Q4 24
6.1%
1.7%
Q3 24
7.1%
2.2%
Q2 24
7.3%
0.1%
Q1 24
6.2%
8.6%
Net Margin
ECG
ECG
PACS
PACS
Q4 25
5.5%
4.4%
Q3 25
5.8%
3.9%
Q2 25
5.7%
3.9%
Q1 25
4.4%
2.2%
Q4 24
4.5%
0.2%
Q3 24
5.5%
1.5%
Q2 24
5.5%
-1.1%
Q1 24
4.5%
5.3%
EPS (diluted)
ECG
ECG
PACS
PACS
Q4 25
$1.09
$0.42
Q3 25
$1.11
$0.32
Q2 25
$1.03
$0.31
Q1 25
$0.72
$0.17
Q4 24
$0.68
$-0.03
Q3 24
$0.82
$0.10
Q2 24
$0.76
$-0.07
Q1 24
$0.55
$0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECG
ECG
PACS
PACS
Cash + ST InvestmentsLiquidity on hand
$197.0M
Total DebtLower is stronger
$281.5M
$353.2M
Stockholders' EquityBook value
$629.8M
$946.8M
Total Assets
$1.7B
$5.6B
Debt / EquityLower = less leverage
0.45×
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECG
ECG
PACS
PACS
Q4 25
$197.0M
Q3 25
$355.7M
Q2 25
$294.2M
Q1 25
$287.5M
Q4 24
$157.7M
Q3 24
$553.0K
$49.5M
Q2 24
$73.4M
Q1 24
$81.2M
Total Debt
ECG
ECG
PACS
PACS
Q4 25
$281.5M
$353.2M
Q3 25
$285.1M
Q2 25
$288.6M
Q1 25
$292.1M
Q4 24
$295.6M
$411.9M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ECG
ECG
PACS
PACS
Q4 25
$629.8M
$946.8M
Q3 25
$573.0M
$871.3M
Q2 25
$514.4M
$806.8M
Q1 25
$460.2M
$750.2M
Q4 24
$422.6M
$709.6M
Q3 24
$453.3M
$660.0M
Q2 24
$490.0M
$572.1M
Q1 24
$464.3M
$128.0M
Total Assets
ECG
ECG
PACS
PACS
Q4 25
$1.7B
$5.6B
Q3 25
$1.6B
$5.6B
Q2 25
$1.5B
$5.5B
Q1 25
$1.4B
$5.5B
Q4 24
$1.3B
$5.2B
Q3 24
$1.3B
$4.5B
Q2 24
$3.9B
Q1 24
$3.9B
Debt / Equity
ECG
ECG
PACS
PACS
Q4 25
0.45×
0.37×
Q3 25
0.50×
Q2 25
0.56×
Q1 25
0.63×
Q4 24
0.70×
0.58×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECG
ECG
PACS
PACS
Operating Cash FlowLast quarter
$48.2M
$-3.4M
Free Cash FlowOCF − Capex
$23.5M
FCF MarginFCF / Revenue
2.3%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
0.87×
-0.06×
TTM Free Cash FlowTrailing 4 quarters
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECG
ECG
PACS
PACS
Q4 25
$48.2M
$-3.4M
Q3 25
$76.2M
$204.8M
Q2 25
$25.3M
$52.6M
Q1 25
$7.1M
$150.2M
Q4 24
$64.6M
Q3 24
$78.9M
$209.2M
Q2 24
$34.8M
Q1 24
$21.9M
$58.8M
Free Cash Flow
ECG
ECG
PACS
PACS
Q4 25
$23.5M
Q3 25
$65.7M
Q2 25
$12.3M
Q1 25
$-11.4M
Q4 24
Q3 24
$60.9M
Q2 24
Q1 24
$12.6M
FCF Margin
ECG
ECG
PACS
PACS
Q4 25
2.3%
Q3 25
6.7%
Q2 25
1.3%
Q1 25
-1.4%
Q4 24
Q3 24
8.0%
Q2 24
Q1 24
2.0%
Capex Intensity
ECG
ECG
PACS
PACS
Q4 25
2.4%
Q3 25
1.1%
Q2 25
1.4%
Q1 25
2.2%
Q4 24
Q3 24
2.4%
Q2 24
Q1 24
1.5%
Cash Conversion
ECG
ECG
PACS
PACS
Q4 25
0.87×
-0.06×
Q3 25
1.34×
3.91×
Q2 25
0.48×
1.03×
Q1 25
0.19×
5.28×
Q4 24
33.78×
Q3 24
1.89×
13.39×
Q2 24
Q1 24
0.77×
1.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

PACS
PACS

Segment breakdown not available.

Related Comparisons